-
2024-514991-41-01
4
Upper Tract Urothelial Carcinoma. Upper urinary tract transitional cel
-
2022-500536-11-00
5
Moderately to severely active ulcerative colitis
-
2022-500537-84-00
5
Moderately to severely active ulcerative colitis
-
2022-502779-40-99
5
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
-
2023-505750-17-00
4
Neovascular age-related macular degeneration
-
2024-518225-15-00
4
Myelofibrosis
-
2024-519246-75-01
4
Patients With Muscle-Invasive Bladder Cancer
-
2024-519895-23-00
10
To analyze whether the anti-rejection treatment of borderline lesions
-
2025-520554-11-00
5
Cardiovascular Disease
-
2025-520711-14-00
4
Allergies
-
2025-521086-28-00
6
CHRONIC INFLAMMATORY RHEUMATIC DISEASE: rheumatoid arthritis or psoria
-
2025-521126-15-00
4
Chronic Myeloid Leukemia
-
2025-521221-32-00
5
Advanced or Metastatic Non-Small Cell Lung Cancer
-
2025-521230-29-00
5
Allergic rhinoconjunctivitis to Dermatophagoides pteronyssinus and Der
-
2025-521694-14-00
6
Patients with diagnosis of Pulmonary Arterial Hypertension of the foll
-
2025-521902-17-00
9
Unresectable/metastatic Small cell Lung Cancer (SCLC)
-
2025-522773-12-00
5
Aetiological treatment of moderate-to-severe allergic rhinitis/rhinoco
-
2025-522791-92-00
5
Neoplasm Metastasis
-
2025-522855-25-00
5
Carcinoma, Transitional Cell
-
2025-523238-17-00
4
Acute myeloid leukemia
-
2025-523259-72-00
5
Hidradenitis Suppurativa (HS)
-
2025-523461-17-01
5
LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
-
2025-523481-24-00
5
Participants with Progressive Supranuclear Palsy Richardson Syndrome (
-
2025-523555-66-00
5
Myelofibrosis